Eizuru Y, Ueno I, Minamishima Y
Department of Microbiology, Miyazaki Medical College, Japan.
J Clin Microbiol. 1988 Sep;26(9):1881-3. doi: 10.1128/jcm.26.9.1881-1883.1988.
Eighteen commercially available immunoglobulin G (IgG) preparations were evaluated by various methods for anti-cytomegalovirus (CMV) antibodies. The modifications of immunoglobulin G molecules, such as sulfonation, alkylation, and enzyme treatments, resulted in profound reductions in anti-CMV antibody titers. However, after reversion in vitro, sulfonated IgG preparations which have been shown to be reverted in vivo (Y. Masuho, K. Tomibe, K. Matsuzawa, T. Watanabe, S. Ishimoto, S. Tsunoda, and T. Noguchi, J. Biochem. 79:1377-1379, 1976) restored the anti-CMV antibody titers to levels comparable with those of nonsulfonated IgG preparations. There is no good correlation among the titers tested by different methods. As a method which reflects the biological activities in vivo, the neutralization test in the presence of complement is suitable for the evaluation of IgG preparations.
通过多种方法对18种市售免疫球蛋白G(IgG)制剂进行了抗巨细胞病毒(CMV)抗体评估。免疫球蛋白G分子的修饰,如磺化、烷基化和酶处理,导致抗CMV抗体滴度大幅降低。然而,体外回复后,已证明在体内可回复的磺化IgG制剂(Y. Masuho、K. Tomibe、K. Matsuzawa、T. Watanabe、S. Ishimoto、S. Tsunoda和T. Noguchi,《生物化学杂志》79:1377 - 1379,1976年)将抗CMV抗体滴度恢复到与未磺化IgG制剂相当的水平。不同方法检测的滴度之间没有良好的相关性。作为一种反映体内生物活性的方法,补体存在下的中和试验适用于评估IgG制剂。